363P Clinical significance of telomerase reverse transcriptase (TERT) promoter mutations, telomere length and MGMT promoter methylation status in newly diagnosed and recurrent IDHwildtype glioblastoma (GBM) patients (PTS): A large mono-institutional study

Giuseppe Lombardi; Silvia Giunco; Francesco Cavallin; Chiara Angelini; Mario Caccese; Giulia Cerretti; Pasquale De Bonis; Anita De Rossi; Vittorina Zagonel

doi:10.1016/j.annonc.2021.08.027

JOURNAL ARTICLE

363P Clinical significance of telomerase reverse transcriptase (TERT) promoter mutations, telomere length and MGMT promoter methylation status in newly diagnosed and recurrent IDHwildtype glioblastoma (GBM) patients (PTS): A large mono-institutional study

Giuseppe Lombardi Silvia Giunco Francesco Cavallin Chiara Angelini Mario Caccese Giulia Cerretti Pasquale De Bonis Anita De Rossi Vittorina Zagonel

Year: 2021 Journal: Annals of Oncology Vol: 32 Pages: S523-S523 Publisher: Elsevier BV

DOI: 10.1016/j.annonc.2021.08.027

Get Full-Text PDF Get Analytical Report

Keywords:

Telomere Medicine Telomerase reverse transcriptase Telomerase Promoter Glioblastoma Cancer research Reverse transcriptase Genetics Gene Biology Polymerase chain reaction Gene expression

Metrics

Cited By

0.00

FWCI (Field Weighted Citation Impact)

Refs

0.15

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Topics

Glioma Diagnosis and Treatment

Health Sciences → Medicine → Genetics

363P Clinical significance of telomerase reverse transcriptase (TERT) promoter mutations, telomere length and MGMT promoter methylation status in newly diagnosed and recurrent IDHwildtype glioblastoma (GBM) patients (PTS): A large mono-institutional study

Metrics

Topics

Related Documents

Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk

The clinical significance of telomerase reverse transcriptase (TERT) promoter mutations, telomere length and O6-methylguanine DNA methyltransferase (MGMT) promoter methylation status in newly diagnosed and recurrent IDHwildtype glioblastoma (GBM) patients (PTS): a large mono-institutional study

Clinical Significance of Telomerase Reverse-Transcriptase Promoter Mutations in Hepatocellular Carcinoma

Highly prevalent telomerase reverse transcriptase ( TERT ) promoter mutations in melanoma